Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T21507 | ||||
Target Name | Fatty acid-binding protein 5 (FABP5) | ||||
Type of Target |
Patented-recorded |
||||
Drug Potency against Target | 2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid | Drug Info | Ki = 3 nM | [2] | |
2-(Carbazole-9-sulfonyl)-benzoic acid | Drug Info | IC50 = 17000 nM | [1] | ||
4-Carbazol-9-yl-butyric acid | Drug Info | IC50 = 6700 nM | [1] | ||
5-Carbazol-9-yl-pentanoic acid | Drug Info | IC50 = 3000 nM | [1] | ||
BMS-480404 | Drug Info | Ki = 33 nM | [2] | ||
Hexadecanoic acid | Drug Info | IC50 = 1200 nM | [1] | ||
References | |||||
REF 1 | Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8. | ||||
REF 2 | NMR structure of a potent small molecule inhibitor bound to human keratinocyte fatty acid-binding protein. J Med Chem. 2006 Aug 10;49(16):5013-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.